Biomarkers play a crucial role in risk assessment by providing quantitative data that can be used to estimate exposure levels, evaluate health risks, and develop regulatory guidelines. They enable more accurate and individualized risk assessments, which can lead to better protection of public health. By integrating biomarkers into risk assessment models, scientists can improve their understanding of dose-response relationships and identify thresholds for adverse effects.
